The INITIATE study: NovoMix 30 shows improved blood glucose control compared with insulin glargine

Editorial Office

Abstract


NovoMix 30, a premix insulin analogue, is more effective than insulin glargine in helping people with type 2 diabetes, who are new to insulin therapy, achieve targeted HbA1c levels, according to a study published in the February issue of Diabetes Care.

Full Text: PDF


This journal is hosted by: OpenJournals Publishing. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.5 South Africa License